Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Buy
5,719
+5,424
+1,839% +$77.6K ﹤0.01% 2428
2026
Q1
$4.77K Buy
+295
New +$3.49K ﹤0.01% 3589
2025
Q4
Sell
-1,587
Closed -$3.46K 4083
2025
Q3
$3.46K Hold
1,587
﹤0.01% 3638
2025
Q2
$2.02K Buy
+1,587
New +$2.13K ﹤0.01% 3870
2024
Q4
Sell
-84
Closed -$229 4191
2024
Q3
$229 Buy
+84
New +$237 ﹤0.01% 4004
2024
Q1
Sell
-741
Closed -$1.58K 4012
2023
Q4
$1.58K Sell
741
-3,130
-81% -$6.6K ﹤0.01% 3738
2023
Q3
$7.63K Buy
3,871
+3,477
+882% +$8.91K ﹤0.01% 3277
2023
Q2
$1.09K Sell
394
-584
-60% -$1.66K ﹤0.01% 3795
2023
Q1
$2.94K Buy
+978
New +$3.56K ﹤0.01% 3677

Other funds holding ERAS

US Bancorp's ERAS Position: Q2 2026 in Review

US Bancorp increased its Erasca (ERAS) stake by 1,839% in Q2 2026, buying an estimated $77.6K and bringing the position to 5,719 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

US Bancorp first reported a position in ERAS in Q1 2023 and has held it in 9 quarters since. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • US Bancorp held 5,719 shares of Erasca worth $105K as of Q2 2026.
  • US Bancorp bought 5,424 Erasca shares in Q2 2026, an estimated $77.6K.
  • Erasca made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2428 holding.
  • US Bancorp first reported a position in Erasca in Q1 2023 and has held it in 9 quarters since.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.